18 Sept 2026, 09:35
Securities Administration—
IMRIMRICOR MEDICAL SYSTEMS INC.
Announcement history available from 1 August 2025
Fromto
18 Sept 2026, 09:34
Securities Administration—
4 Sept 2026, 17:10
OtherMS
3 Sept 2026, 08:21
Company UpdateMS
28 Aug 2026, 17:17
Securities Administration—
28 Aug 2026, 08:16
Company UpdateMS
10 Aug 2026, 08:50
Company UpdateMS
10 Aug 2026, 08:39
Presentations—
10 Aug 2026, 08:39
Periodic ReportsMS
10 Aug 2026, 08:38
Periodic ReportsMS
7 Aug 2026, 08:31
Company UpdateMS
4 Aug 2026, 08:58
Presentations—
27 July 2026, 08:34
Company UpdateMS
20 July 2026, 09:25
Company UpdateMS
14 July 2026, 17:19
Securities Administration—
13 July 2026, 11:35
Securities Administration—
13 July 2026, 11:30
Securities Administration—
2 July 2026, 08:33
Company UpdateMS
26 June 2026, 08:58
Securities Administration—
11 June 2026, 08:55
Company UpdateMS
27 May 2026, 09:13
Securities Administration—
21 May 2026, 09:36
Securities Administration—
21 May 2026, 09:33
Securities Administration—
20 May 2026, 09:57
Director Interests—
20 May 2026, 09:56
Director Interests—
20 May 2026, 09:56
Director Interests—
20 May 2026, 09:55
Director Interests—
20 May 2026, 09:53
Director Interests—
20 May 2026, 09:34
Securities Administration—
19 May 2026, 18:00
Substantial Holders—
18 May 2026, 09:44
Securities Administration—
18 May 2026, 09:26
Company Update—
8 May 2026, 12:09
Meetings & Governance—
8 May 2026, 10:37
Securities Administration—
8 May 2026, 10:33
Securities Administration—
8 May 2026, 09:27
Securities Administration—
8 May 2026, 08:23
Presentations—
8 May 2026, 08:22
Letters & Addresses—
4 May 2026, 09:49
Presentations—
4 May 2026, 09:12
Securities Administration—
4 May 2026, 09:12
Capital RaisingMS
30 Apr 2026, 09:59
Trading Halt / SuspensionMS
30 Apr 2026, 09:51
Trading Halt / SuspensionMS
28 Apr 2026, 08:25
Quarterly ReportsMS
27 Apr 2026, 08:43
Company UpdateMS
16 Apr 2026, 16:15
Securities Administration—
8 Apr 2026, 08:44
Company UpdateMS
27 Mar 2026, 09:26
Presentations—
27 Mar 2026, 09:24
Financial Results—
27 Mar 2026, 09:20
Company Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 18 Sept 2026, 09:35 | Cleansing Notice | Securities Administration | — | 06018 | |
| 18 Sept 2026, 09:34 | Application for quotation of securities - IMR | Securities Administration | — | 06020 | |
| 4 Sept 2026, 17:10 | S&P DJI Announces September 2026 Quarterly Rebalance | Other | MS | — | |
| 3 Sept 2026, 08:21 | FDA Accepts Imricor PMA Manufacturing Module | Company Update | MS | 11001 | |
| 28 Aug 2026, 17:17 | Release from Voluntary Escrow | Securities Administration | — | 06009 | |
| 28 Aug 2026, 08:16 | Imricor and Philips Launch Commercial iMR Lab Solution | Company Update | MS | 11001 | |
| 10 Aug 2026, 08:50 | Imricor U.S. Commercial Momentum Accelerates | Company Update | MS | 11001 | |
| 10 Aug 2026, 08:39 | 1H 2026 Investor Presentation | Presentations | — | 03026 | |
| 10 Aug 2026, 08:39 | 2026 Q2 Form 10-Q | Periodic Reports | MS | 03014 | |
| 10 Aug 2026, 08:38 | Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission | Periodic Reports | MS | 03014 | |
| 7 Aug 2026, 08:31 | Philips Declares Compatibility with Imricor | Company Update | MS | 11001 | |
| 4 Aug 2026, 08:58 | Q2 FY26 Results Webinar Notification | Presentations | — | 03027, 14014 | |
| 27 July 2026, 08:34 | Imricor Launches U.S. Commercial Operations | Company Update | MS | 11001 | |
| 20 July 2026, 09:25 | Imricor Submits All Remaining 510(k) Devices to FDA | Company Update | MS | 11001 | |
| 14 July 2026, 17:19 | Notification regarding unquoted securities - IMR | Securities Administration | — | 06021 | |
| 13 July 2026, 11:35 | Cleansing Notice | Securities Administration | — | 06018 | |
| 13 July 2026, 11:30 | Application for quotation of securities - IMR | Securities Administration | — | 06020 | |
| 2 July 2026, 08:33 | Imricor Receives FDA Pediatric Clearances for iMR Device | Company Update | MS | 11001 | |
| 26 June 2026, 08:58 | Form S-8 Registration Statement | Securities Administration | — | 06009 | |
| 11 June 2026, 08:55 | Submission of the Third PMA Module to the US FDA for Review | Company Update | MS | 11001 | |
| 27 May 2026, 09:13 | Granting of ASX Waiver - US Financial Reporting Requirements | Securities Administration | — | 12016 | |
| 21 May 2026, 09:36 | Notification of cessation of securities - IMR | Securities Administration | — | 06027 | |
| 21 May 2026, 09:33 | Update - Notification regarding unquoted securities - IMR | Securities Administration | — | 06021 | |
| 20 May 2026, 09:57 | Appendix 3Y - AD | Director Interests | — | 02009 | |
| 20 May 2026, 09:56 | Appendix 3Y - PM | Director Interests | — | 02009 | |
| 20 May 2026, 09:56 | Appendix 3Y - AM | Director Interests | — | 02009 | |
| 20 May 2026, 09:55 | Appendix 3Y - MT | Director Interests | — | 02009 | |
| 20 May 2026, 09:53 | Appendix 3Y - SW | Director Interests | — | 02009 | |
| 20 May 2026, 09:34 | Notification regarding unquoted securities - IMR | Securities Administration | — | 06021 | |
| 19 May 2026, 18:00 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 18 May 2026, 09:44 | Application for quotation of securities - IMR | Securities Administration | — | 06020 | |
| 18 May 2026, 09:26 | Amendment to Form 10 | Company Update | — | 11001, 12008 | |
| 8 May 2026, 12:09 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 May 2026, 10:37 | Cleansing Notice | Securities Administration | — | 06018 | |
| 8 May 2026, 10:33 | Application for quotation of securities - IMR | Securities Administration | — | 06020 | |
| 8 May 2026, 09:27 | Release from Voluntary Escrow | Securities Administration | — | 06009 | |
| 8 May 2026, 08:23 | AGM Presentation Slides | Presentations | — | 03026 | |
| 8 May 2026, 08:22 | Chair's Address for AGM | Letters & Addresses | — | 15002 | |
| 4 May 2026, 09:49 | Equity Raising Presentation | Presentations | — | 03026 | |
| 4 May 2026, 09:12 | Proposed issue of securities - IMR | Securities Administration | — | 06013 | |
| 4 May 2026, 09:12 | Imricor Completes Successful A$60 Million Capital Raise | Capital Raising | MS | 06003, 09014 | |
| 30 Apr 2026, 09:59 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 Apr 2026, 09:51 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 28 Apr 2026, 08:25 | Imricor Q1 CY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 27 Apr 2026, 08:43 | Amendment to Form 10 | Company Update | MS | 11001, 12008 | |
| 16 Apr 2026, 16:15 | Notification regarding unquoted securities - IMR | Securities Administration | — | 06021 | |
| 8 Apr 2026, 08:44 | Imricor Submits NorthStar for U.S. Pediatric Expansion | Company Update | MS | 11001 | |
| 27 Mar 2026, 09:26 | Notice of Annual Stockholders Meeting and CDI Voting Form | Presentations | — | 08001, 08004, 14014, 16002 | |
| 27 Mar 2026, 09:24 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03020 | |
| 27 Mar 2026, 09:20 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 |
1–50 of 88
1 / 2